Optimizing Every Step: An End-to-End Workflow for High-Confidence Single-Cell Proteomics
Kick off the Single-Cell Proteomics Webinar Series with a complete workflow overviewâfrom sample prep to LC-MS and data analysisâpowered by Thermo Fisher Scientific technologies.
RECORD
|
Already taken place Tu, 10.3.2026
Thermo Fisher Scientific
From Raw Materials to Conjugation Sites: Advanced LC, MS and MALS Strategies for AOC Characterization and Monitoring
This webinar explores the comprehensive analysis of Antibody Oligonucleotide Conjugates (AOCs) using LC-MS and LC-MALS.
RECORD
|
Already taken place Th, 5.3.2026
Waters Corporation
SureQuant Hybrid DIA
Free workshop on SureQuant hybrid DIA using Orbitrap Astral and Proteome Discovererâlearn targeted peptide quantification with isotopic standards.
RECORD
|
Already taken place Tu, 3.3.2026
Thermo Fisher Scientific
Getting Peptide Characterization Right: Analytical and Regulatory Foundations for Confident Development
Episode 1 of Peptide 360 explores the analytical and regulatory foundations of peptide characterization, showing how integrated LC-MS enable compliant, decision-ready GLP-1 development.
RECORD
|
Already taken place Fr, 27.2.2026
Agilent Technologies
4D performance gains for highly multiplexed gut microbiome metabolite quantification
Learn how the Thermo Scientific LC-MSâż workflow accelerates multiplexed targeted quantitation using mzCloud and Stellar MS, enabling faster method development with broader coverage and higher confidence.
RECORD
|
Already taken place Th, 26.2.2026
Thermo Fisher Scientific
Toward early detection of congenital disease using Orbitrap Astral DIA MS/MS
Learn how Orbitrap Astral MS in DIA mode enables ultra-sensitive detection of parasite-specific IgG variants to improve early diagnosis of congenital toxoplasmosis.
RECORD
|
Already taken place Th, 26.2.2026
Thermo Fisher Scientific
Single cell and immunopeptidomics explorations on Orbitrap Astral MS
Discover how Orbitrap Astral MS and Vanquish Neo HPLC enable >5,000 protein IDs per single cell and deep immunopeptidome coverage from ultra-low-input clinical samples.
RECORD
|
Already taken place Th, 19.2.2026
Thermo Fisher Scientific
Driving the process development of recombinant therapeutic products with automated MS-based target peptide mapping
Webinar on automated MS-based MAM workflows for peptide mapping, faster CMC decisions, and scalable analytics from development to QC readiness.
RECORD
|
Already taken place Tu, 17.2.2026
Thermo Fisher Scientific
Comprehensive Analytical Strategies for Peptides Therapeutics and GLP-1 Agonist with Agilent
Explore analytical workflows for peptide therapeuticsâcovering method development, peptide mapping, GLP-1 QC, and LC-MS strategies using Agilent Technologies platforms.
RECORD
|
Already taken place Th, 12.2.2026
Thermo Fisher Scientific
Introducing the Orbitrap Excedion Pro Hybrid MS
Discover the new Orbitrap Exploris Pro and its expanded ETD/EThcD capabilities for confident biopharmaceutical characterization, including intact proteins, PTMs, ADCs, and large biomolecules.
RECORD
|
Already taken place Th, 12.2.2026
Thermo Fisher Scientific
Â
Related content
How Bitter Acid Analysis Helps Brewers Better Control Beer Flavors
Tu, 30.6.2026
Thermo Fisher Scientific
Interlaboratory comparisons other than proficiency testing